{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:10:38Z","timestamp":1793329838277,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Project in Natural Science Research in Higher Education Institutions of Anhui Province","award":["2023AH051777"],"award-info":[{"award-number":["2023AH051777"]}]},{"name":"the Key project of Natural Science Foundation of Wannan Medical College","award":["WK2022ZF29"],"award-info":[{"award-number":["WK2022ZF29"]}]},{"name":"the Climbing Scientific Peak Project for Talents, the Second Affiliated Hospital of Wannan Medical College","award":["DFJH2022018"],"award-info":[{"award-number":["DFJH2022018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03498-z","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:19:30Z","timestamp":1765430370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FBXW7 regulates MAP7 through ubiquitination to affect the phenotypic characteristics and paclitaxel sensitivity of paclitaxel-resistant lung adenocarcinoma cells"],"prefix":"10.1186","volume":"30","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"3","key":"3498_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3498_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764\u201374.","journal-title":"JAMA"},{"issue":"5","key":"3498_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2022.02.005","volume":"17","author":"R Fujikawa","year":"2022","unstructured":"Fujikawa R, Muraoka Y, Kashima J, Yoshida Y, Ito K, Watanabe H, et al. Clinicopathologic and genotypic features of lung adenocarcinoma characterized by the International Association for the Study of Lung Cancer grading system. J Thorac Oncol. 2022;17(5):700\u20137.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"3498_CR4","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2174\/1570180820666230505123802","volume":"21","author":"DK Dwivedi","year":"2024","unstructured":"Dwivedi DK, Agrawal RK, Jain S, Kuche K. Design, synthesis and cytotoxic studies of novel 4-anilinoquinazoline derivatives of potential agents for non-small-cell lung cancer. Lett Drug Des Discov. 2024;21(10):1801\u201318.","journal-title":"Lett Drug Des Discov"},{"issue":"3","key":"3498_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/0118744710254730231114181358","volume":"17","author":"K Ayse G\u00fclbin","year":"2024","unstructured":"Ayse G\u00fclbin K, Ihsan K, Ahmet S, Seniz D, Abdullah Tuncay D. Impact of radiation therapy on serum humanin and MOTS-c levels in patients with lung or breast cancer. Curr Radiopharm. 2024;17(3):229\u201337.","journal-title":"Curr Radiopharm"},{"key":"3498_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102403","volume":"67","author":"X Pu","year":"2024","unstructured":"Pu X, Lin G, Xiao M, Lin J, Wang Q, Kong Y, et al. Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study. EClinicalMedicine. 2024;67:102403.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3498_CR7","doi-asserted-by":"publisher","first-page":"2313671","DOI":"10.1080\/07853890.2024.2313671","volume":"56","author":"H Xu","year":"2024","unstructured":"Xu H, Du Z, Li Z, Liu X, Li X, Zhang X, et al. MUC1-EGFR crosstalk with IL-6 by activating NF-\u03baB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma. Ann Med. 2024;56(1):2313671.","journal-title":"Ann Med"},{"issue":"7782","key":"3498_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309.","journal-title":"Nature"},{"issue":"4","key":"3498_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2174\/1570180820666221214152939","volume":"21","author":"S Ballav","year":"2024","unstructured":"Ballav S, Lokhande KB, Sahu VK, Yadav RS, Swamy KV, Basu S. Identification of novel PPAR-\u03b2\/\u03b4 agonists from Kaempferol, Quercetin, and Resveratrol derivatives by targeting cancer: an integrative molecular docking and dynamics simulation approach. Lett Drug Des Discov. 2024;21(4):749\u201362.","journal-title":"Lett Drug Des Discov"},{"issue":"6578","key":"3498_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1126\/science.abf6154","volume":"375","author":"LS Ferro","year":"2022","unstructured":"Ferro LS, Fang Q, Eshun-Wilson L, Fernandes J, Jack A, Farrell DP, et al. Structural and functional insight into regulation of kinesin-1 by microtubule-associated protein MAP7. Science (New York, NY). 2022;375(6578):326\u201331.","journal-title":"Science (New York, NY)"},{"issue":"4","key":"3498_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1083\/jcb.201808065","volume":"218","author":"PJ Hooikaas","year":"2019","unstructured":"Hooikaas PJ, Martin M, M\u00fchlethaler T, Kuijntjes GJ, Peeters CAE, Katrukha EA, et al. Map7 family proteins regulate kinesin-1 recruitment and activation. J Cell Biol. 2019;218(4):1298\u2013318.","journal-title":"J Cell Biol"},{"issue":"5","key":"3498_CR12","first-page":"721","volume":"52","author":"R Wang","year":"2022","unstructured":"Wang R, Xie S, He Y, Zheng R, Zhang M, Jin J, et al. MAP7 promotes breast cancer cell migration and invasion by regulating the NF-B pathway. Ann Clin Lab Sci. 2022;52(5):721\u201330.","journal-title":"Ann Clin Lab Sci"},{"key":"3498_CR13","doi-asserted-by":"publisher","first-page":"34546","DOI":"10.1038\/srep34546","volume":"6","author":"L Fu","year":"2016","unstructured":"Fu L, Fu H, Zhou L, Xu K, Pang Y, Hu K, et al. High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia. Sci Rep. 2016;6:34546.","journal-title":"Sci Rep"},{"issue":"2","key":"3498_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.21873\/invivo.13123","volume":"37","author":"C Cacina","year":"2023","unstructured":"Cacina C, Ulu E, Arikan S, Surmen ST, Yaylim I. The investigation of MAPK7 gene variations in colorectal cancer risk. In Vivo. 2023;37(2):644\u20138.","journal-title":"In Vivo"},{"issue":"3","key":"3498_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/1120009X.2022.2082349","volume":"35","author":"X Wang","year":"2023","unstructured":"Wang X, Cao X, Wu Y, Chen T. Map7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel. J Chemother. 2023;35(3):231\u20139.","journal-title":"J Chemother"},{"key":"3498_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216643","volume":"584","author":"QN Wu","year":"2024","unstructured":"Wu QN, Qi J, Liu ZK, Luo XJ, Yu K, Lu YX, et al. HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer. Cancer Lett. 2024;584:216643.","journal-title":"Cancer Lett"},{"issue":"1","key":"3498_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23(1):148.","journal-title":"Mol Cancer"},{"issue":"9","key":"3498_CR18","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1172\/JCI99257","volume":"128","author":"S Rizzolio","year":"2018","unstructured":"Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, et al. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies. J Clin Invest. 2018;128(9):3976\u201390.","journal-title":"J Clin Invest"},{"issue":"4","key":"3498_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2023.01.006","volume":"58","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH, et al. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell. 2023;58(4):320-334.e328.","journal-title":"Dev Cell"},{"issue":"1","key":"3498_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13062-024-00532-8","volume":"19","author":"Z Hu","year":"2024","unstructured":"Hu Z, Wu Y, Sun X, Tong Y, Qiu H, Zhuo E. ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation. Biol Direct. 2024;19(1):82.","journal-title":"Biol Direct"},{"key":"3498_CR21","doi-asserted-by":"publisher","first-page":"1278056","DOI":"10.3389\/fphar.2023.1278056","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang K, Liu X, Li J, Zhou W, Wang C, et al. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. Front Pharmacol. 2023;14:1278056.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3498_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12885-024-11841-6","volume":"24","author":"Y Lu","year":"2024","unstructured":"Lu Y, He W, Huang X, Xiao X. Pulsatilla saponin D regulates ras-related C3 botulinum toxin substrate 3 (RAC3) to overcome resistance to paclitaxel in lung adenocarcinoma cells. BMC Cancer. 2024;24(1):55.","journal-title":"BMC Cancer"},{"issue":"36","key":"3498_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205091","volume":"9","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Huang S, Tan X, Long L, He Q, Liang X, et al. N(6)-Methyladenosine-modified CBX1 regulates nasopharyngeal carcinoma progression through heterochromatin formation and STAT1 activation. Adv Sci. 2022;9(36):e2205091.","journal-title":"Adv Sci"},{"key":"3498_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.680402","volume":"11","author":"J Luo","year":"2021","unstructured":"Luo J, Hu Q, Gou M, Liu X, Qin Y, Zhu J, et al. Expression of microtubule-associated proteins in relation to prognosis and efficacy of immunotherapy in non-small cell lung cancer. Front Oncol. 2021;11:680402.","journal-title":"Front Oncol"},{"issue":"12","key":"3498_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s13238-019-0652-x","volume":"10","author":"H Lan","year":"2019","unstructured":"Lan H, Sun Y. FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded. Protein Cell. 2019;10(12):861\u20133.","journal-title":"Protein Cell"},{"issue":"1","key":"3498_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-022-01548-2","volume":"21","author":"J Fan","year":"2022","unstructured":"Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, et al. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer. 2022;21(1):87.","journal-title":"Mol Cancer"},{"issue":"1","key":"3498_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"CH Yeh","year":"2018","unstructured":"Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17(1):115.","journal-title":"Mol Cancer"},{"issue":"12","key":"3498_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309902121","volume":"121","author":"M Boretto","year":"2024","unstructured":"Boretto M, Geurts MH, Gandhi S, Ma Z, Staliarova N, Celotti M, et al. Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7. Proc Natl Acad Sci USA. 2024;121(12):e2309902121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3498_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s12276-021-00721-9","volume":"54","author":"HJ An","year":"2022","unstructured":"An HJ, Lee CJ, Lee GE, Choi Y, Jeung D, Chen W, et al. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells. Exp Mol Med. 2022;54(1):35\u201346.","journal-title":"Exp Mol Med"},{"key":"3498_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115446","volume":"209","author":"X Mo","year":"2023","unstructured":"Mo X, Shen X, Mo X, Yu F, Tan W, Deng Z, et al. CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7\/c-Myc-dependent axis. Biochem Pharmacol. 2023;209:115446.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"3498_CR31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41374-022-00812-9","volume":"102","author":"H Zhu","year":"2022","unstructured":"Zhu H, Wang X, Zhou X, Lu S, Gu G, Liu C. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination. Lab Invest. 2022;102(11):1203\u201313.","journal-title":"Lab Invest"},{"issue":"1","key":"3498_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.abd.2021.12.005","volume":"98","author":"H Chen","year":"2023","unstructured":"Chen H, Xu K, Sun C, Gui S, Wu J, Wang S. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K\/AKT\/mTOR pathway. An Bras Dermatol. 2023;98(1):26\u201335.","journal-title":"An Bras Dermatol"},{"issue":"6","key":"3498_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/1878-0261.12200","volume":"12","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Yin C, Wang Y, Lv H, Wang W, Huang Y, et al. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy. Mol Oncol. 2018;12(6):883\u201395.","journal-title":"Mol Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03498-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:19:31Z","timestamp":1765430371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3498"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03498-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1230"}}